Showing results (1-10 of 22) with videos related to
Sort By:
Pageof 3
Current Opinion in Pharmacology|November 20, 2001
Heterodimerization of G-protein-coupled receptors in the CNSF H MarshallCurrent Opinion in Drug Discovery & Development|August 4, 2009
Molecular insight develops our understanding of the GABA(B) receptorF H MarshallBritish Journal of Pharmacology|May 23, 2013
Binding kinetics differentiates functional antagonism of orexin-2 receptor ligandsR Mould, J Brown, F H Marshall, et al.British Journal of Pharmacology|April 1, 1990
Characterization of cholecystokinin octapeptide-stimulated endogenous dopamine release from rat nucleus accumbens in vitroF H Marshall, S Barnes, R D Pinnock, et al.The Journal of Biological Chemistry|June 2, 2001
Protein-protein interaction and not glycosylation determines the binding selectivity of heterodimers between the calcitonin receptor-like receptor and the receptor activity-modifying proteinsS Hilairet, S M Foord, F H Marshall, et al.Pain|April 26, 2002
CB1 and CB2 cannabinoid receptors are implicated in inflammatory painN Clayton, F H Marshall, C Bountra, et al.Biochemical Society Transactions|August 5, 2000
GABA(B) receptors function as heterodimersF H Marshall, J White, M Main, et al.European Journal of Pharmacology|December 27, 1995
Temperature and agonist dependency of tachykinin NK1 receptor antagonist potencies in rat isolated superior cervical ganglionA B Hawcock, I J Beresford, F H Marshall, et al.British Journal of Pharmacology|July 1, 1993
Binding of angiotensin antagonists to rat liver and brain membranes measured ex vivoF H Marshall, S A Clark, A D Michel, et al.Journal of Neurochemistry|March 1, 1991
Cholecystokinin modulates the release of dopamine from the anterior and posterior nucleus accumbens by two different mechanismsF H Marshall, S Barnes, J Hughes, et al.Pageof 3